AI PRICE FORECAST
GEHC Stock Forecast & AI Price Prediction
GE HealthCare Technologies · Healthcare · Medical Devices
GEHC live signal snapshot
Shares of GEHC were last at $82.60, down 1.26% on the day, trading 8.0% below its 52-week high of $89.77 and 40.6% above its 52-week low of $58.75. The model's verdict for GEHC right now: BUY (86% confidence). The short-term averages line up bullishly, and the price is holding above its 50-day line. Its one-month projection is about $85.48, a 3.5% move from the last price.
GEHC's 14-day RSI is 74.7 — overbought territory, where short-term pullbacks or consolidation are common. The MACD indicator sits over its signal line, and the histogram reading of 0.65 shows buying pressure building. Its 50-day average ($70.06) is holding 0.2% above the 200-day ($69.90), the pattern chartists call a golden cross.
20 Wall Street analysts covering GEHC put the average price target at $87.85 (range $75.00–$100.00), implying 6.4% upside from the current price. The current recommendation trend leans bullish: 15 Buy/Strong Buy ratings vs 0 Sell/Strong Sell (and 7 Hold).
Live figures from real market data feeds, current as of the last site build. Open the interactive GEHC dashboard for numbers updated throughout today's session.
About GE HealthCare Technologies
GE HealthCare Technologies Inc. (GEHC) is a medical devices company in the healthcare sector, headquartered in Chicago, IL, United States. GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada,… It has a market value of about $37.3 billion and roughly 54,000 full-time employees. Its beta of 0.77 means it has historically moved roughly in line with the market.
GEHC performance vs. the market
Year to date, GEHC has gained 0.7%, behind the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). Over the past 12 months the stock has gained 12.4%, roughly in line with the S&P 500. Its +20.1% move over the past month extends a +11.9% three-month run.
| Period | GEHC | Sector (XLV) | S&P 500 |
|---|---|---|---|
| 1 month | +20.1% | +11.4% | −2.3% |
| 3 months | +11.9% | +12.2% | −2.3% |
| Year to date | +0.7% | +22.1% | +11.4% |
| 1 year | +12.4% | +28.3% | +11.5% |
GE HealthCare Technologies financials at a glance
GE HealthCare Technologies's most recent quarter (ended Sep 30, 2026) brought in $5.5 billion of revenue and net income of $615 million (a 11.2% net margin). Revenue was up 7.2% from the same quarter a year earlier. The stock trades at a price-to-earnings ratio of 17.5 on trailing earnings of $4.73 per share. Trailing free cash flow was $1.8 billion, and total debt equals 88% of shareholders' equity.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Sep 30, 2026 | $5.5B | $615M |
| Jun 30, 2026 | $5.3B | $561M |
| Mar 31, 2026 | $5.1B | $389M |
| Dec 31, 2025 | $5.7B | $589M |
GEHC vs. its peers
GEHC's +0.7% this year ranks ahead of 3 of the 5 big healthcare names below. The strongest of the group this year is Edwards Lifesciences (EW, +24.1%).
| Company | Price | YTD | P/E | AI verdict |
|---|---|---|---|---|
| GE HealthCare Technologies (GEHC) | $82.60 | +0.7% | 17.5 | BUY |
| Abbott Laboratories (ABT) | $109.29 | −12.8% | 40.8 | HOLD |
| Medtronic (MDT) | $101.61 | +5.8% | 25.0 | HOLD |
| Stryker (SYK) | $318.79 | −9.3% | 33.9 | HOLD |
| Boston Scientific (BSX) | $45.13 | −52.7% | 19.0 | HOLD |
| Edwards Lifesciences (EW) | $105.81 | +24.1% | 61.5 | BUY |
GEHC stock: common questions
What is the GEHC stock price target?
20 Wall Street analysts put the average 12-month target at $87.85, in a range of $75.00–$100.00, versus a recent price of $82.60. Stock Pulse 247's model projects about $85.48 over the next month.
Is GEHC a buy right now?
Our AI model currently rates GEHC a BUY at 86% confidence. Among analysts, 15 rate it Buy or Strong Buy, 7 Hold and 0 Sell. Neither is personal advice — weigh them with your own research and risk tolerance.
How has GEHC stock performed this year?
Year to date, GEHC has gained 0.7%, behind the S&P 500 (+11.4%) and behind the healthcare sector fund XLV (+22.1%). Over the past 12 months the stock has gained 12.4%, roughly in line with the S&P 500. Its +20.1% move over the past month extends a +11.9% three-month run.
What is GEHC's 52-week high and low?
GEHC has traded between $58.75 and $89.77 over the past 52 weeks; at $82.60 it is 8.0% below its 52-week high of $89.77 and 40.6% above its 52-week low of $58.75.
What sector is GEHC in, and who are its peers?
GEHC is in the healthcare sector (medical devices). Its largest peers on Stock Pulse 247 include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Boston Scientific (BSX).
How accurate is the GEHC forecast?
It's a model estimate from price history, technical indicators and analyst targets, not a guarantee — no model predicts short-term moves reliably. Use it as one input alongside your own research.
How this works: the forecast combines GEHC's price history, momentum indicators (RSI, MACD, moving averages), volatility and analyst targets into one estimate. It's a model, not a guarantee.